Chronic obstructive pulmonary disease (COPD) is a serious public health problem, and is
often related to smoking.[1] In advanced
stages of COPD, the presence of PAH is a common development. PAH progression rate in
COPD is usually slow (an increase of < 1 mmHg per year). However, the presence of
even moderate PAH is a strong predictor of mortality.[2] During stable periods of the disease, the increase in mean
pulmonary artery pressure is usually mild to moderate. However, severe PAH may
occasionally occur in COPDpatientsCOPD.[3]Conventional two-dimensional (2D) echo parameters allow a reasonable assessment of RV
Function. In the 1990s, the use of tissue Doppler (TD) to measure the intramyocardial
velocity gradient allowed measuring the rate of myocardial strain and its percentage
(strain rate and strain). About ten years ago, the speckle tracking technique, based on
the tracking of the speckles which two-dimensional echo images, allowed assessing
myocardial strain without limitation by the DT insonation angle.[4] 2D-STE strain can not only quantify the
overall RV function, but it can also identify discrete, localized contractile losses,
providing information regarding the pathophysiological mechanisms that lead to right
ventricular failure.[5] In a
heterogeneous group of patients, RV lateral wall longitudinal strain showed a strong
correlation with RV ejection fraction calculated by cardiac magnetic
resonance.[6] Peak longitudinal
strain is a significant prognostic determinant in PAHpatients, with greater value
compared to other known clinical and echocardiographic predictors of
mortality.[7]Several studies have used 2D-STE in chronic PAHpatients. Several authors advocate this
method for serial evaluation of PAHpatients since RV free-wall strain has proved an
independent predictor of clinical deterioration and mortality after medical therapy is
initiated.[8] Although 2D-STE is
widely used in various clinical conditions, the guidelines on echocardiographic
evaluation of RV function strongly recommends including other measures into
echocardiographic examination and report.[9] In addition to the fact that there are no reference values, RV ST2D
can be influenced by image quality, reverberation and other artifacts.[10]The literature clearly shows the benefit of pulmonary rehabilitation (PR) programs. A
prospective randomized study showed the effectiveness of respiratory training as an
additional treatment of severe chronic PAH.[11] In this issue, Kanar et al. evaluated the RV function using
2D-STE with 46 COPD and 32 control patients.[12] The authors compared the 2D-STE values for the two groups and
for patients before and after a pulmonary rehabilitation program. The conventional
parameters for 2D-echo and 2D-STE showed a similar correlation between COPD and control
patients, but RV longitudinal strain showed greater sensitivity in examining the
relationship between RV function and exercise tolerance. The main limitations are
pointed out in the article. There is no information on whether 2D-STE measurements were
made in apnea or at the time of pre and post PR breathing. Since RV is sensitive to
preload variations, the values could be influenced by respiratory variation. In any
case, the usefulness of ST2D to evaluate RV in COPD was well demonstrated. Although
there is controversy on the effectiveness of pulmonary rehabilitation programs in
PAH,[13] the authors
demonstrated in an original way, i.e., through ST2D, that RV improves after PR, thus
creating new perspectives for the use of PR in COPDpatients.
Authors: Alessandra Meris; Francesco Faletra; Cristina Conca; Catherine Klersy; François Regoli; Julia Klimusina; Maria Penco; Elena Pasotti; Giovanni B Pedrazzini; Tiziano Moccetti; Angelo Auricchio Journal: J Am Soc Echocardiogr Date: 2010-06-19 Impact factor: 5.251
Authors: Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt Journal: Eur Heart J Cardiovasc Imaging Date: 2015-03 Impact factor: 6.875
Authors: Marlieke L A Haeck; Roderick W C Scherptong; Nina Ajmone Marsan; Eduard R Holman; Martin J Schalij; Jeroen J Bax; Hubert W Vliegen; Victoria Delgado Journal: Circ Cardiovasc Imaging Date: 2012-08-08 Impact factor: 7.792
Authors: Derliz Mereles; Nicola Ehlken; Sandra Kreuscher; Stefanie Ghofrani; Marius M Hoeper; Michael Halank; F Joachim Meyer; Gabriele Karger; Jan Buss; Jana Juenger; Nicole Holzapfel; Christian Opitz; Jörg Winkler; Felix F J Herth; Heinrike Wilkens; Hugo A Katus; Horst Olschewski; Ekkehard Grünig Journal: Circulation Date: 2006-09-18 Impact factor: 29.690
Authors: Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983